Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery

Ophthalmology

Volumn 108, Issue 6, 2001, Pages 1033-1038

  Chen, Teresa C ^a,c   Ang, Robert T ^a   Grosskreutz, Cynthia L ^a   Pasquale, Louis R ^a   Fan, Joseph T ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; APRACLONIDINE; BRIMONIDINE;

ADULT; AGED; ARGON LASER; ARTICLE; CAPSULOTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; INTRAOCULAR HYPERTENSION; IRIDOTOMY; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRABECULOPLASTY;

ADRENERGIC ALPHA-AGONISTS; AGED; ANTERIOR EYE SEGMENT; BLOOD PRESSURE; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; GLAUCOMA, OPEN-ANGLE; HEART RATE; HUMANS; INTRAOCULAR PRESSURE; IRIS; LASER SURGERY; MALE; OCULAR HYPERTENSION; OPHTHALMIC SOLUTIONS; POSTOPERATIVE COMPLICATIONS; QUINOXALINES; SAFETY; TRABECULECTOMY;

EID: 0034982103     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00545-0     Document Type: Article

References (36)

1. Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma
2. Immediate intraocular pressure response to argon laser trabeculoplasty
3. Effects of ALO 2145 on intraocular pressure following argon laser trabeculoplasty
4. Chronic use of apraclonidine decreases its moderation of post-laser intraocular pressure spikes
5. Complications of laser trabeculoplasty
6. Early complications following Q-switched neodymium: YAG laser posterior capsulotomy
7. Effect of pilocarpine in treatment of intraocular pressure elevation following neodymium: YAG posterior capsulotomy
8. Intraocular pressure changes after neodymium-YAG laser posterior capsulotomy
9. The effect of apraclonidine on the intraocular pressure of glaucoma patients following Nd: YAG laser posterior capsulotomy
10. Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium: YAG posterior capsulotomy
11. Prophylactic use of apraclonidine for intraocular pressure increase after Nd: YAG capsulotomies
12. A comparison of neodymium: YAG and argon laser iridotomies
13. Acute intraocular pressure response to argon laser iridotomy
14. Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd: YAG laser iridotomy
15. Effect of apraclonidine hydrochloride on acute intraocular pressure rise after argon laser iridotomy
16. Medical management of acute postoperative intraocular pressure rises associated with anterior segment ophthalmic laser surgery
17. The glaucoma laser trial. I. Acute effects of argon laser trabeculoplasty in intraocular pressure
18. Laser iridectomy. A controlled study comparing argon and neodymium: YAG
19. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy
20. Intraocular pressure change after neodymium: YAG capsulotomy
21. Argon laser trabeculoplasty medical therapy to prevent the intraocular pressure rise associated with argon laser trabeculoplasty
22. Follow-up of argon laser trabeculoplasty: Is a day one postoperative IOP check necessary?
23. The role of apraclonidine hydrochloride in laser therapy for glaucoma
24. Prevention of the rise in intraocular pressure following neodymium: YAG posterior capsulotomy using topical 1% apraclonidine
25. Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery
26. Effects of topical ALO 2145 (p-aminoclonidine hydrochloride) on the acute intraocular pressure rise after argon laser iridotomy
27. Apraclonidine 0.5% versus 1.0% for controlling intraocular pressure elevation after argon laser trabeculoplasty
28. Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise
29. The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine
30. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial
31. Effect of brimonidine 0.5% on intraocular pressure spikes following 360° argon laser trabeculoplasty
32. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty
33. The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty
34. Brimonidine tartrate: A one-month dose response study
35. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures
36. Intraocular pressure elevation following Nd: YAG laser posterior capsulotomy